Montserrat Torres a, Guiomar Casado a, Lorena Vigón a, Sara Rodríguez-Mora a, b, Elena Mateos a, b, Fernando Ramos-Martín a, Daniel López-Wolf c, José Sanz-Moreno d, Pablo Ryan-Murua e, María Luisa Taboada-Martínez f, María Rosa López-Huertas a, b, Miguel Cervero g, Mayte Coiras a, b, ⁎
on behalf of Multidisciplinary Group of Study of COVID19 (MGS-COVID)1, Contributing members of the Multidisciplinary Group of Study of COVID-19 (in alphabetical order)
a Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain
b Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Spain
c Internal Medicine Service, Hospital Universitario Fundación Alcorcón, Alcorcón, Spain
d Internal Medicine Service, Hospital Universitario Príncipe de Asturias, Alcalá Henares, Spain
e Internal Medicine Service, Hospital Universitario Infanta Leonor, Madrid, Spain
f Internal Medicine Service, Hospital Universitario de Cabueñes, Gijón, Spain
g Internal Medicine Service, Hospital Universitario Severo Ochoa, Leganés, Spain